Welcome to our dedicated page for Seer news (Ticker: $SEER), a resource for investors and traders seeking the latest updates and insights on Seer stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Seer's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Seer's position in the market.
Seer, Inc. (Nasdaq: SEER), a life sciences company, reported Q1 2024 financial results. Achieved $3.1M in revenue, expanded STAC program to Europe, validated Proteograph Product Suite, launched Insights Grant Program, authorized $25M share repurchase program. Experienced a 24% revenue decrease primarily from product and related party revenue. Operating expenses decreased by 10%. Net loss was $20.7M. Cash position at $359.2M. Board authorized $25M share repurchase program. Full year revenue guidance for 2024 is $16-18M.
Seer, Inc. (Nasdaq: SEER) has launched a new Seer Technology Access Center in Bonn, Germany, to provide European life sciences researchers with access to the Seer Proteograph™ Product Suite and mass spectrometry technologies. The facility aims to support unbiased proteomic studies, accelerate biomarker discovery, and drug development. The European STAC will offer programs to enhance the availability of state-of-the-art proteomics technologies and assist researchers in expanding their research scope.